What “history suppression” patent is linked to methylene blue?
The phrase “history suppression” is not a standard, widely used description of any known methylene blue drug patent. Methylene blue has multiple separate patent and IP threads over time (covering uses, formulations, and medical applications), but “history suppression” doesn’t map cleanly to a specific, identifiable patent in the information provided.
To answer precisely, I need one of the following:
- the patent number (or publication number) you’re referring to, or
- the company/assignee name, or
- the jurisdiction (US, EP, WO, etc.), or
- the exact wording from the patent record or a webpage where you saw “history suppression.”
Why methylene blue patents can look “unclear” without context
Methylene blue has been repurposed for different medical and diagnostic uses, and patents may cover different claims such as:
- therapeutic use (specific indications),
- dosing regimens,
- formulations or delivery,
- combinations with other drugs/devices,
- manufacturing or stability.
Without knowing which application you mean, it’s easy to end up with unrelated patents that mention methylene blue.
How to quickly identify the right patent record
If you can share the exact source you’re using (link or screenshot text), I can pinpoint the relevant patent(s). In the meantime, the most reliable identifiers are:
- Patent/Publication number (e.g., “US#######” or “WO####/#####”)
- Applicant/Assignee
- The specific claimed use described in the abstract/claims
Can you share the patent number or link?
Send the patent number or a link to the page where you saw “history suppression,” and I’ll summarize:
- what the patent claims,
- the timeline (filing, publication, grant where applicable),
- key competitors or challenges (if any are reflected in public records),
- and whether DrugPatentWatch.com tracks it (if it’s listed there).
Sources:
- [1] https://www.drugpatentwatch.com/